Ovid Therapeutics Insider Trades
NASDAQ: OVIDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 2.51 +2.03%
Last 12 months
- Purchases
- 0 · $0
- Sales
- 2 · $29.29K
- Shares bought / sold
- 0 / 20.20K
- Net activity
- Net selling $29,286
Ovid Therapeutics insider activity
Over the last 12 months, Ovid Therapeutics insiders reported 10 transactions on SEC Form 4: 0 open-market purchases and 2 sales. Insiders bought $0 and sold $29,286 worth of stock, for net insider selling of $29,286. The largest seller was ALEXANDER MARGARET A., with $16,901 in reported sales.
The most recent filing shows Carter Charles Ross (Chief Financial Officer) reporting a transaction in 50,000 shares on Jul 6, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put OVID's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
OVID insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jul 6, 2026 | Carter Charles RossChief Financial Officer | Award | 50,000 | — | Form 4 |
| Apr 7, 2026 | Fitzgerald Kevin JosephDirector | Award | 17,578 | $45.00K | Form 4 |
| Apr 7, 2026 | Friedman BartDirector | Award | 8,789 | $22.50K | Form 4 |
| Apr 7, 2026 | PAPADOPOULOS STELIOSDirector | Award | 17,578 | $45.00K | Form 4 |
| Mar 23, 2026 | LEVIN JEREMY MExecutive Chairman | Option exercise | 47,333 | $66.27K | Form 4 |
| Feb 26, 2026 | Rona Jeffrey ACBFO | Award | 68,125 | — | Form 4 |
| Feb 23, 2026 | Rona Jeffrey ACBFO | Sale | 8,541 | $12.38K | Form 4 |
| Feb 23, 2026 | ALEXANDER MARGARET A.President and CEO | Sale | 11,656 | $16.90K | Form 4 |
| Dec 15, 2025 | LEVIN JEREMY MCEO | Conversion | 71,000 | — | Form 4 |
| Dec 8, 2025 | TAKEDA PHARMACEUTICAL CO LTD & Takeda Pharmaceuticals U.S.A., Inc.10% Owner | Conversion | 1,250,000 | — | Form 4 |
| Feb 26, 2025 | Rona Jeffrey ACBFO | Sale | 3,902 | $2.19K | Form 4 |
| Feb 26, 2025 | ALEXANDER MARGARET A.President and COO | Sale | 5,279 | $2.96K | Form 4 |
| Feb 20, 2025 | ALEXANDER MARGARET A.President and COO | Award | 43,750 | — | Form 4 |
| Feb 20, 2025 | Rona Jeffrey ACBFO | Award | 43,750 | — | Form 4 |
| Jan 27, 2025 | ALEXANDER MARGARET A.President and COO | Buy | 6,810 | $4.97K | Form 4 |
| Mar 18, 2024 | LEVIN JEREMY MCEO | Buy | 18,248 | $50.36K | Form 4 |
| Feb 22, 2024 | Tardio JasonChief Operating Officer | Award | 28,125 | — | Form 4 |
| Feb 22, 2024 | Perone Thomas MichaelGeneral Counsel, Secretary | Award | 28,125 | — | Form 4 |
| Feb 22, 2024 | Rona Jeffrey ACBFO | Award | 28,125 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4